DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Zolpidem Postmarketing Study in Adolescent Patients With Insomnia

Information source: Astellas Pharma Inc
Information obtained from ClinicalTrials.gov on October 19, 2009
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Insomnia

Intervention: Zolpidem (Myslee®) (Drug); placebo (Drug)

Phase: Phase 4

Status: Recruiting

Sponsored by: Astellas Pharma Inc

Official(s) and/or principal investigator(s):
Use Central Contact, Study Chair, Affiliation: Astellas Pharma Inc

Overall contact:
Clinical Development Administration Dept, Email: clinicaltrials_info@jp.astellas.com

Summary

To investigate the efficacy and safety of zolpidem for pediatric insomniacs in a randomized double blind-controlled trial

Clinical Details

Official title: Zolpidem Postmarketing Clinical Study: A Double Blind, Placebo Controlled Group Comparative Trial in the Adolescent Patients With Insomnia

Study design: Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Placebo Control, Parallel Assignment, Safety/Efficacy Study

Primary outcome: Mean daily sleep latency for double-blind period

Secondary outcome:

Mean daily total hours of sleep

Mean daily frequency of intermediate awaking

Mean daily time of intermediate awaking

Impression of patient for double-blind period

Eligibility

Minimum age: 12 Years. Maximum age: 18 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- patients diagnosed as having nonorganic insomnia of nonorganic sleep disorder in

ICD10

- patients whose age at the time of obtaining consent is 12 years or over and 18 years

or below

Exclusion Criteria:

- patients with schizophrenia or manic-depressive illness

- patients with insomnia caused by physical diseases

- patients having a history of hypersensitivity to zolpidem

- patients with attention-deficit hyperactivity disorder

Locations and Contacts

Clinical Development Administration Dept, Email: clinicaltrials_info@jp.astellas.com

Kanto region, Japan; Recruiting

Chubu region, Japan; Recruiting

Kansai region, Japan; Recruiting

Chugoku region, Japan; Recruiting

Shikoku region, Japan; Recruiting

Hokkaido region, Japan; Recruiting

Kyushyu region, Japan; Recruiting

Additional Information

Starting date: February 2007
Ending date: January 2010
Last updated: September 8, 2009

Page last updated: October 19, 2009

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009